Human Monoclonal Antibodies against Pseudomonas aeruginosa Lipopolysaccharide Derived from Transgenic Mice Containing Megabase Human Immunoglobulin Loci Are Opsonic and Protective against Fatal Pseudomonas Sepsis

Pseudomonas aeruginosa is a significant human pathogen, and no vaccine is commercially available. Passive antibody prophylaxis using monoclonal antibodies (MAb) against protective P. aeruginosa epitopes is an alternative strategy for preventing P. aeruginosa infection, but mouse MAb are not suitable...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hemachandra, Sonali, Kamboj, Kulwant, Copfer, Janna, Pier, Gerald, Green, Larry L., Schreiber, John R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2001
Gaiak:
Microbial Immunity and Vaccines
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC98149/
https://ncbi.nlm.nih.gov/pubmed/11254577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.69.4.2223-2229.2001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak